Fluvastatin Prevents Cardiac Death and Myocardial Infarction in Renal Transplant Recipients: Post-Hoc Subgroup Analyses of the ALERT Study
Authors:
Open Access
- 2 April 2004
- journal article
- clinical trial
- Published by Elsevier in American Journal of Transplantation
- Vol. 4 (6) , 988-995
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Cardiovascular risk in patients with mild renal insufficiencyKidney International, 2003
- Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)JAMA, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Cancer incidence in a kidney-transplanted populationTransplant International, 2000
- Cancer incidence in a kidney-transplanted populationTransplant International, 2000
- CHOLESTEROL AS AN INDEPENDENT PREDICTOR OF OUTCOME AFTER RENAL TRANSPLANTATIONTransplantation, 2000
- Fluvastatin in combination with cyclosporin in renal transplant recipients: a review of clinical and safety experience. REVIEW ARTICLEJournal of Clinical Pharmacy and Therapeutics, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- ISCHEMIC HEART DISEASE—MAJOR CAUSE OF DEATH AND GRAFT LOSS AFTER RENAL TRANSPLANTATION IN SCANDINAVIATransplantation, 1995
- Plasma cholesterol, coronary heart disease, and cancer in the Renfrew and Paisley survey.BMJ, 1989